These data suggest that CD8+ T cells expressing BTLA in NSCLC microenvironment exhibit exhausted phenotype and are correlated with clinical response to anti-PD-1 therapy in NSCLC patients. This evidence concerns the gene PDCD1 and non-small cell lung carcinoma.